Digital therapeutics company, HealthBeacon, has listed on the Euronext Growth Dublin, raising €25m in funding.
Shares were priced at €5.85 at flotation, valuing the business at €98.5m.
The Dublin headquartered firm develops products for managing injectable medications for people in the home.
"HealthBeacon is delighted to be joining Euronext Growth in what is another important milestone on our journey towards connecting people to better health through digitally enabled solutions," said Jim Joyce, CEO of HealthBeacon.
"The support from investors through this listing is transformative for the business, enabling us to scale to meet potential demand, as we aim to become the world's leading digital therapeutics platform for injectable medications."
HealthBeacon was listed through the admission to trading of the 16,812,047 shares making up its equity and of 4,273,504 new shares issued in the placement phase.
The company says it intends to use the proceeds of the IPO to grow its team to support growth across sales and marketing, customer support and operations, finance and product development
It also intends to build inventory and boost working capital as part of its product roll out.
The firm also wants to further develop its platform and pipeline through research and development.
The company expects to see a ten-fold jump in the number of patients using its systems between now and the end of 2023.
